Welcome to LookChem.com Sign In|Join Free
  • or
2(1H)-Pyrimidinone, 5-(1,1-dimethylethyl)- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

133271-21-3

Post Buying Request

133271-21-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133271-21-3 Usage

Category

Heterocyclic organic compound

Uses

Pharmaceutical intermediate in drug development and synthesis processes

Structure

Pyrimidine ring with a tertiary butyl group attached to the 5-position of the ring

Medicinal Properties

Potential medicinal properties, studied for its role in various biological processes

Handling Precautions

Handle and use with caution due to potential health hazards and environmental impacts.

Check Digit Verification of cas no

The CAS Registry Mumber 133271-21-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,2,7 and 1 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 133271-21:
(8*1)+(7*3)+(6*3)+(5*2)+(4*7)+(3*1)+(2*2)+(1*1)=93
93 % 10 = 3
So 133271-21-3 is a valid CAS Registry Number.

133271-21-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-tert-butylpyrimidin-2(1H)-one

1.2 Other means of identification

Product number -
Other names 5-t-butylpyrimidin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:133271-21-3 SDS

133271-21-3Relevant academic research and scientific papers

PYRIDAZINONES AS PARP7 INHIBITORS

-

Paragraph 2072, (2019/11/11)

The present invention relates to pyridazinones and related compounds which are inhibitors of PARP7 and are useful in the treatment of cancer.

PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

-

Page/Page column 90, (2014/11/11)

The invention relates to new pyrrolidine derivatives of the formula (I), wherein R1 to R3, Ar, L T and n are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceu

PYRIMIDINE-SUBSTITUTED PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

-

Paragraph 0366; 0371, (2014/10/29)

The invention relates to new pyrrolidine derivatives of the formula wherein R1 to R3, Ar, L T and n are as defined in the description and claims, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical

AZETIDINE DERIVATIVES

-

Paragraph 0652, (2013/06/28)

Azetidine derivatives of which the following is exemplary and their use in the treatment of obesity, diabetes or dyslipidemia.

NEW AZIRIDINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS

-

Page/Page column 103, (2013/07/05)

The invention relates to new azetidine derivatives of the formula (I) wherein Ar1, Ar2, X, R, T and L are as defined in the description, to their use as medicaments, to methods for their therapeutic use and to pharmaceutical compositions containing them.

The Synthesis of Some Lipophilic Tetradentate Ligands for Use in the Formation of Metal-Linked Polymers

Crossley, Maxwell J.,Gorjian, Sargon,Sternhell, Sever,Tansey, Kerrie M.

, p. 723 - 738 (2007/10/02)

Two lipophilic tetradentate ligands, 5,5'-di-t-butyl- and 5,5'-dihexyl-2,2'-bipyrimidine, were prepared via either Ullmann or nickel(0)-promoted reactions in low but useful yields.Approaches towards the synthesis of lipophilic ligands based on 2,2'-biimidazole, namely 4,4',5,5'-tetrabutyl-2,2'-biimidazole (from decane-4,5-dione) and various 4,4',5,5'-tetra(arylamino)-2,2'-biimidazoles (from 4,4',5,5'-tetrabromo-2,2'-biimidazole and arylamines), and a 2,2'-bibenzimidazole, 5,5',6,6'-tetra(octyloxy)-2,2'-bibenzimidazole (from N,N'-bisoxamide), were uniformly unsuccessful for preparing the 2,2'-biheteroaryl compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 133271-21-3